The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Elevated Pontine and Putamenal GABA Levels in Mild-Moderate Parkinson Disease Detected by 7 Tesla Proton MRS
Open accessAbstract
BACKGROUND: Parkinson disease (PD) is characterized by the degeneration of nigrostriatal dopaminergic neurons. However, postmortem evidence indicates that the pathology of lower brainstem regions, such as the pons and medulla, precedes nigral involvement. Consistently, pontomedullary damage was implicated by structural and PET imaging in early PD. Neurochemical correlates of this early pathological involvement in PD are unknown. METHODOLOGY/PRINCIPAL FINDING: To map biochemical alterations in the brains of individuals with mild-moderate PD we quantified neurochemical profiles of the pons, putamen and substantia nigra by 7 tesla (T) proton magnetic resonance spectroscopy. Thirteen individuals with idiopathic PD (Hoehn & Yahr stage 2) and 12 age- and gender-matched healthy volunteers participated in the study. γ-Aminobutyric acid (GABA) concentrations in the pons and putamen were significantly higher in patients (N = 11, off medications) than controls (N = 11, p<0.001 for pons and p<0.05 for putamen). The GABA elevation was more pronounced in the pons (64%) than in the putamen (32%). No other neurochemical differences were observed between patients and controls. CONCLUSION/SIGNIFICANCE: The GABA elevation in the putamen is consistent with prior postmortem findings in patients with PD, as well as with in vivo observations in a rodent model of PD, while the GABA finding in the pons is novel. The more significant GABA elevation in the pons relative to the putamen is consistent with earlier pathological involvement of the lower brainstem. This study provides in vivo evidence for an alteration in the GABAergic tone in the lower brainstem and striatum in early-moderate PD, which may underlie disease pathogenesis and may provide a biomarker for disease staging.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jenkinson, M., Bannister, P., Brady, M., & Smith, S. (2002) · NeuroImage · doi:10.1006/nimg.2002.1132 · Cited by 11,888
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · cited 2×
“Since Braak suggested a caudorostral progression of a-synuclein pathology in PD starting in the medulla oblongata [2,41], only one study has investigated the neurochemistry of the pons in PD with MRS [12].”
BackgroundBias between MNI and Talairach coordinates analyzed using the ICBM‐152 brain template
Lancaster, J. L., Tordesillas‐Gutiérrez, D., Martinez, M., Salinas, F., Evans, A., Zilles, K., Mazziotta, J. C., & Fox, P. T. (2007) · Human Brain Mapping · doi:10.1002/hbm.20345 · Cited by 1,464
Sasaki, M., Shibata, E., Tohyama, K., Takahashi, J., Otsuka, K., Tsuchiya, K., Takahashi, S., Ehara, S., Terayama, Y., & Sakai, A. (2006) · Neuroreport · doi:10.1097/01.wnr.0000227984.84927.a7 · Cited by 496 · cited 1×
“Additionally, neuronal loss in the pons has been indicated by several in vivo MRI studies as a reduction in the neuromelaninrelated signal localized to the LC [42] and atrophy of the pons/ medulla detected by voxel based morphometry [7].”
In vivo 1 H NMR spectroscopy of the human brain at 7 T
Tkáč, I., Andersen, P., Adriany, G., Merkle, H., Uǧurbil, K., & Gruetter, R. (2001) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1213 · Cited by 394
Progression of monoaminergic dysfunction in parkinson's disease: a longitudinal 18f-dopa pet study
Pavese, N., Rivero-Bosch, M., Lewis, S. J., Whone, A. L., & Brooks, D. J. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.03.012 · Cited by 145
Cited by
Clinical Proton MR Spectroscopy in Central Nervous System Disorders
Öz, G., Alger, J. R., Barker, P. B., Bartha, R., Bizzi, A., Boesch, C., Bolan, P. J., Brindle, K. M., Cudalbu, C., Dinçer, A., et al. (2014) · Radiology · doi:10.1148/radiol.13130531 · Cited by 660
Self-citationA genetically encoded fluorescent sensor for in vivo imaging of GABA
Marvin, J. S., Shimoda, Y., Magloire, V., Leite, M., Kawashima, T., Jensen, T. P., Kolb, I., Knott, E. L., Novak, O., Podgorski, K., et al. (2019) · Nature Methods · doi:10.1038/s41592-019-0471-2 · Cited by 354
Magnetic Resonance Spectroscopy to Assess NeuroInflammation and Neuropathic Pain
Chang, L., Munsaka, S. M., Kraft-Terry, S., & Ernst, T. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9460-x · Cited by 305
Mishra, A., Singh, S., & Shukla, S. (2018) · Journal of Experimental Neuroscience · doi:10.1177/1179069518779829 · Cited by 276
Magnetic resonance imaging for the diagnosis of Parkinson’s disease
Heim, B., Krismer, F., De Marzi, R., & Seppi, K. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1717-8 · Cited by 272
“MRS In PD, 1H-MRS studies have reported reduced NAA as well as elevated lactate and choline, while other studies failed to detect these changes (Bowen et al. 1995; O’Neill et al. 2002; Esterhammer et al. 2010; Guevara et al. 2010; Brockmann et al. 2012; Emir et al. 2012; Levin et al. 2014; Weiduschat et al. 2015).”
Background
Metadata
- Authors
- Emir, U. E., Tuite, P. J., & Öz, G.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-01-25
- Volume
- 7
- Issue
- 1
- Pages
- e30918
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2093459949
- Cited by
- 176
- References
- 6
- FWCI
- 10.28
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.